PART I As used in this Report, unless the context otherwise requires, references to we, us, our, Company, Tivic, and Tivic Health refer to Tivic Health Systems, Inc, collectively with its subsidiary, on a consolidated basis. Business Overview Tivic Health Systems, Inc. is a late-stage biopharmaceutical company whose lead program is Entolimod. Entolimod is a recombinant TLR5 agonist with an extensive preclinical and clinical data package supporting development as a medical countermeasure (MCM) fo...
Q2 FY2026 — expected 2026-08-16
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-30 | 2025-12-31 | 0001437749-26-010343 | EDGAR | 108K words |
| 2025-03-21 | 2024-12-31 | 0000950170-25-043234 | EDGAR | — |
| 2024-03-25 | 2023-12-31 | 0000950170-24-035946 | EDGAR | — |
| 2023-03-31 | 2022-12-31 | 0000950170-23-011359 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0001104659-22-041068 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-14 | 2025-09-30 | 0001437749-25-035216 | EDGAR | 40K words |
| 2025-08-14 | 2025-06-30 | 0000950170-25-108977 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0000950170-25-072752 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0000950170-24-127072 | EDGAR | — |
| 2024-08-14 | 2024-06-30 | 0000950170-24-097056 | EDGAR | — |
| 2024-05-15 | 2024-03-31 | 0000950170-24-060534 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0000950170-23-063771 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0000950170-23-042520 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0000950170-23-022256 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0000950170-22-025033 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001410578-22-002554 | EDGAR | — |
| 2022-05-16 | 2022-03-31 | 0001410578-22-001666 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-25 | 0001437749-26-009789 | EDGAR | 1K words |
| 2026-03-20 | 0001683168-26-002064 | EDGAR | — |
| 2026-03-13 | 0001683168-26-001781 | EDGAR | — |
| 2026-03-11 | 0001683168-26-001687 | EDGAR | — |
| 2026-03-04 | 0001683168-26-001461 | EDGAR | — |
| 2026-02-09 | 0001683168-26-000877 | EDGAR | — |
| 2026-01-20 | 0001683168-26-000398 | EDGAR | — |
| 2025-12-11 | 0001683168-25-009079 | EDGAR | — |
| 2025-11-18 | 0001437749-25-035521 | EDGAR | — |
| 2025-11-14 | 0001437749-25-035208 | EDGAR | — |
145 total filings indexed. 118 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001787740 |
| Ticker | TIVC |
| Exchange | Nasdaq |
| SIC | 3845: Electromedical & Electrotherapeutic Apparatus |
| Incorporated | DE |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report